Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Nov;36(5):470–473. doi: 10.1111/j.1365-2125.1993.tb00399.x

Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

W N Charman 1, S A Charman 1, D C Monkhouse 1, S E Frisbee 1, E A Lockhart 1, S Weisman 1, G A Fitzgerald 1
PMCID: PMC1364623  PMID: 12959298

Abstract

The release of aspirin from a 75 mg controlled-release formulation, designed to inhibit maximally thromboxane A2 production while sparing stimulated prostacyclin biosynthesis, was characterised in healthy subjects. The calculated in vivo release rate of aspirin matched the design goal of approximately 10 mg h(-1). The C(max) of aspirin associated with the controlled-release formulation was lowered 15-fold relative to a solution formulation of the same dose. The bioavailability of aspirin (based on salicylate concentrations) from the controlled-release formulation was approximately 90% relative to the solution, and drug release was not affected by co-administration of a standard breakfast.

Full text

PDF
470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baenziger N. L., Becherer P. R., Majerus P. W. Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts. Cell. 1979 Apr;16(4):967–974. doi: 10.1016/0092-8674(79)90111-9. [DOI] [PubMed] [Google Scholar]
  2. Bhagwat S. S., Hamann P. R., Still W. C., Bunting S., Fitzpatrick F. A. Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature. 1985 Jun 6;315(6019):511–513. doi: 10.1038/315511a0. [DOI] [PubMed] [Google Scholar]
  3. Bogentoft C., Carlsson I., Ekenved G., Magnusson A. Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms. Eur J Clin Pharmacol. 1978 Dec 18;14(5):351–355. doi: 10.1007/BF00611905. [DOI] [PubMed] [Google Scholar]
  4. Braden G. A., Knapp H. R., FitzGerald G. A. Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin. Circulation. 1991 Aug;84(2):679–685. doi: 10.1161/01.cir.84.2.679. [DOI] [PubMed] [Google Scholar]
  5. Bunting S., Gryglewski R., Moncada S., Vane J. R. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976 Dec;12(6):897–913. doi: 10.1016/0090-6980(76)90125-8. [DOI] [PubMed] [Google Scholar]
  6. Clarke R. J., Mayo G., Price P., FitzGerald G. A. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin. N Engl J Med. 1991 Oct 17;325(16):1137–1141. doi: 10.1056/NEJM199110173251605. [DOI] [PubMed] [Google Scholar]
  7. DeWitt D. L., Smith W. L. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1412–1416. doi: 10.1073/pnas.85.5.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FitzGerald G. A., Lupinetti M., Charman S. A., Charman W. N. Presystemic acetylation of platelets by aspirin: reduction in rate of drug delivery to improve biochemical selectivity for thromboxane A2. J Pharmacol Exp Ther. 1991 Dec;259(3):1043–1049. [PubMed] [Google Scholar]
  9. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hanley S. P., Bevan J., Cockbill S. R., Heptinstall S. A regimen for low-dose aspirin? Br Med J (Clin Res Ed) 1982 Nov 6;285(6351):1299–1302. doi: 10.1136/bmj.285.6351.1299. [DOI] [PubMed] [Google Scholar]
  11. Hennekens C. H., Buring J. E., Sandercock P., Collins R., Peto R. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation. 1989 Oct;80(4):749–756. doi: 10.1161/01.cir.80.4.749. [DOI] [PubMed] [Google Scholar]
  12. Mojaverian P., Rocci M. L., Jr, Conner D. P., Abrams W. B., Vlasses P. H. Effect of food on the absorption of enteric-coated aspirin: correlation with gastric residence time. Clin Pharmacol Ther. 1987 Jan;41(1):11–17. doi: 10.1038/clpt.1987.3. [DOI] [PubMed] [Google Scholar]
  13. Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982 Jun;69(6):1366–1372. doi: 10.1172/JCI110576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Pedersen A. K., FitzGerald G. A. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase. N Engl J Med. 1984 Nov 8;311(19):1206–1211. doi: 10.1056/NEJM198411083111902. [DOI] [PubMed] [Google Scholar]
  15. Per cent absorbed versus time plots from metabolite level in blood. J Pharm Sci. 1965 Jul;54(7):1075–1076. doi: 10.1002/jps.2600540734. [DOI] [PubMed] [Google Scholar]
  16. Reilly I. A., FitzGerald G. A. Aspirin in cardiovascular disease. Drugs. 1988 Feb;35(2):154–176. doi: 10.2165/00003495-198835020-00005. [DOI] [PubMed] [Google Scholar]
  17. Rowland M., Riegelman S., Harris P. A., Sholkoff S. D. Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci. 1972 Mar;61(3):379–385. doi: 10.1002/jps.2600610312. [DOI] [PubMed] [Google Scholar]
  18. WAGNER J. G., NELSON E. Per cent absorbed time plots derived from blood level and/or urinary excretion data. J Pharm Sci. 1963 Jun;52:610–611. doi: 10.1002/jps.2600520629. [DOI] [PubMed] [Google Scholar]
  19. Willard J. E., Lange R. A., Hillis L. D. The use of aspirin in ischemic heart disease. N Engl J Med. 1992 Jul 16;327(3):175–181. doi: 10.1056/NEJM199207163270308. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES